Down-regulation of MET, the receptor for hepatocyte growth factor

被引:0
|
作者
Dean E Hammond
Sylvie Urbé
George F Vande Woude
Michael J Clague
机构
[1] Physiological Laboratory,
[2] University of Liverpool,undefined
[3] Van Andel Research Institute,undefined
来源
Oncogene | 2001年 / 20卷
关键词
Met; hepatocyte growth factor; endocytosis; proteasome;
D O I
暂无
中图分类号
学科分类号
摘要
The ligand-dependent degradation of activated tyrosine kinase receptors provides a means by which mitogenic signalling can be attenuated. In many cell types the ligand-dependent degradation of the tyrosine kinase receptor Met is completely dependent on the activity of the 26S proteasome (Jeffers et al., 1997b). We now show that degradation also requires trafficking to late endosomal compartments and the activity of acid dependent proteases as determined by the effects of a dominant negative form of dynamin (K44A) and a vacuolar-ATPase inhibitor, concanamycin. We show that in the presence of the proteasome inhibitor lactacystin, Met fails to redistribute from the plasma membrane to intracellular compartments. This observation is most consistent with the interpretation that proteasome activity is required for Met internalization and only indirectly for its degradation.
引用
收藏
页码:2761 / 2770
页数:9
相关论文
共 50 条
  • [21] SCATTER FACTOR AND HEPATOCYTE GROWTH-FACTOR ARE INDISTINGUISHABLE LIGANDS FOR THE MET RECEPTOR
    NALDINI, L
    WEIDNER, KM
    VIGNA, E
    GAUDINO, G
    BARDELLI, A
    PONZETTO, C
    NARSIMHAN, RP
    HARTMANN, G
    ZARNEGAR, R
    MICHALOPOULOS, GK
    BIRCHMEIER, W
    COMOGLIO, PM
    EMBO JOURNAL, 1991, 10 (10): : 2867 - 2878
  • [22] Sustained down-regulation of the epidermal growth factor receptor by decorin -: A mechanism for controlling tumor growth in vivo
    Csordás, G
    Santra, M
    Reed, CC
    Eichstetter, I
    McQuillan, DJ
    Gross, D
    Nugent, MA
    Hajnóczky, G
    Iozzo, RV
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) : 32879 - 32887
  • [23] Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization
    Hughes, Juliana Bentes
    Berger, Christian
    Rodland, Marianne Skeie
    Hasmann, Max
    Stang, Espen
    Madshus, Inger Helene
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (07) : 1885 - 1892
  • [24] Down-regulation of hepatocyte growth factor mRNA in rat cardiac myocytes under hypoxia mimicked by cobalt chloride
    Su, Y
    Li, HW
    Zhang, J
    Xiu, RJ
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2006, 34 (1-2) : 201 - 206
  • [25] Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma
    Tuck, AB
    Park, M
    Sterns, EE
    Boag, A
    Elliott, BE
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (01): : 225 - 232
  • [26] HEPATOCYTE GROWTH-FACTOR RECEPTOR AND THE C-MET ONCOGENE
    FAUSTO, N
    HEPATOLOGY, 1991, 14 (04) : 738 - 740
  • [27] The hepatocyte growth factor receptor, Met, in prostate cancer invasion and metastasis
    Knudsen, BS
    You, X
    Gmyrek, G
    Vaughan, ED
    Vande Woude, G
    LABORATORY INVESTIGATION, 2002, 82 (01) : 167A - 168A
  • [28] Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis
    Rampino, T
    Gregorini, M
    Camussi, G
    Conaldi, PG
    Soccio, G
    Maggio, M
    Bottelli, A
    Dal Canton, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (06) : 1066 - 1074
  • [29] The hepatocyte growth factor receptor, Met, in prostate cancer invasion and metastasis
    Knudsen, BS
    You, X
    Gmyrek, G
    Vaughan, ED
    Vande Woude, G
    MODERN PATHOLOGY, 2002, 15 (01) : 167A - 168A
  • [30] DOWN-REGULATION OF THE INTERFERON RECEPTOR
    BRANCA, AA
    BAGLIONI, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1982, 257 (22) : 13197 - 13200